Common Drug Review, as it relates to health technology assessments and drug product reimbursement recommendations.
Engagement with the Advisory Committee on the Implementation of National Pharmacare and its Secretariat on issues related to access to medicines and rare disorder and orphan drug policies
Federal programs and budgetary initiatives related to the Federal-Provincial-Territorial funding arrangements regarding pharmaceuticals.
Federally-funded Public Drug Plans, with respect to reimbursement for drug products for federal plan beneficiaries.
Innovation, Science and Economic Development Canada Innovation and Skills Strategy and other government policies and programs related to incentivizing research and development activities in Canada.
Règlement
Proposals to amend guidelines related to the operationalization of the legislation and regulations governing the Patented Medicine Prices Review Board